Nmdae for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Nov 2021: Trial registered, NCT05136755
  2. 25 Jan 2022: Trial started, NCT05136755

The trials

NCT05136755: NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder

State
Under way
Phase
Phase 2
People
50 planned
Started
25 Jan 2022
Primary completion
Nov 2026
Arms
NMDAE
Results
None posted
  1. 29 Nov 2021: Trial registered
  2. 25 Jan 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.